Darmstadt, Germany - Effective July 1, 2015, Evonik Industries AG will globally increase the prices for selected product types of its PMMA molding compounds, which it markets under the PLEXIGLAS® and PLEXIMID® trademarks (ACRYLITE® and ACRYMID® in the Americas). As far as permissible under existing agreements and according to the product type, the increase will amount to up to a double-digit percentage.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2014 more than 33,000 employees generated sales of around €12.9 billion and an operating profit (adjusted EBITDA) of about €1.9 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.